Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital

Abstract

Background: Prevailing insulin regimens for glycemic control in hospitalized patients have changed over time. We aimed to de-termine whether the current basal-bolus insulin (BBI) regimen is superior to the previous insulin regimen, mainly comprising split-mixed insulin therapy. Methods: This was a single tertiary center, retrospective observational study that included non-critically ill patients with type 2 diabetes mellitus who were treated with split-mixed insulin regimens from 2004 to 2007 (period 1) and with BBI from 2008 to 2018 (period 2). Patients from each period were analyzed after propensity score matching. The mean difference in glucose levels and the achievement of fasting and preprandial glycemic targets by day 6 of admission were assessed. The total daily insulin dose, incidence of hypoglycemia, and length of hospital stay were also evaluated. Results: Among 244 patients from each period, both fasting glucose (estimated mean +/- standard error, 147.4 +/- 3.1 mg/dL vs. 129.4 +/- 3.2 mg/dL, P< 0.001, day 6) and preprandial glucose (177.7 +/- 2.8 mg/dL vs. 152.8 +/- 2.8 mg/dL, P< 0.001, day 6) were lower in period 2 than in period 1. By day 6 of hospital admission, 42.6% and 67.2% of patients achieved a preprandial glycemic target of <140 mg/dL in periods 1 and 2, respectively (relative risk, 2.00; 95% confidence interval, 1.54 to 2.59), without an increased in-cidence of hypoglycemia. Length of stay was shorter in period 2 (10.23 +/- 0.26 days vs. 8.70 +/- 0.26 days, P< 0.001). Conclusion: BBI improved glycemic control in a more efficacious manner than a split-mixed insulin regimen without increasing the risk of hypoglycemia in a hospital setting.